Ethical and legal issues in mitochondrial transfer
Open Access
- 21 April 2016
- journal article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 8 (6) , 589-591
Abstract
The US National Academies of Science, Engineering and Medicine recently provided conditional endorsement for mitochondrial transfer. While its approach is more conservative in some respects than that of the United Kingdom (which passed its own regulations in 2015), it marks a significant policy development for a potentially large implementer of this emerging intervention. In this perspective, we consider some of the ethical and legal aspects of these policy responses.Keywords
Funding Information
- Wellcome (097897/Z/11/Z)
This publication has 9 references indexed in Scilit:
- Rendered invisible? The absent presence of egg providers in U.K. debates on the acceptability of research and therapy for mitochondrial diseaseMonash Bioethics Review, 2015
- Should uterus transplants be publicly funded?Journal of Medical Ethics, 2015
- The “Three-Parent Baby”: A Case Study of How Language Frames the Ethical Debate Regarding an Emerging TechnologyThe American Journal of Bioethics, 2015
- Mitochondrial Replacement: Ethics and IdentityBioethics, 2015
- The hidden risks for ‘three-person’ babiesNature, 2015
- Concise Reviews: Assisted Reproductive Technologies to Prevent Transmission of Mitochondrial DNA DiseaseStem Cells, 2015
- THE ETHICS OF UTERUS TRANSPLANTATIONBioethics, 2011
- Lessons Across the Pond: Assisted Reproductive Technology in the United Kingdom and the United StatesAmerican Journal of Law & Medicine, 2005
- Artificial gametes: new paths to parenthood?Journal of Medical Ethics, 2005